Ignite Creation Date:
2025-12-24 @ 4:36 PM
Ignite Modification Date:
2025-12-27 @ 8:28 AM
Study NCT ID:
NCT00294866
Status:
COMPLETED
Last Update Posted:
2010-04-08
First Post:
2006-02-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients
Sponsor:
Fresenius Medical Care North America
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
2005002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Mark Kaplan, M.D., Vice President of Clinical Research
Old Organization:
Fresenius Medical Care North America
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |